Retatrutide added two more Phase 3 wins.
September 3, 2026
Lilly’s TRIUMPH-2 enrolled 1,152 adults with obesity or overweight and type 2 diabetes. At 80 weeks, the 12 mg group...
Read More
September 3, 2026Lilly’s TRIUMPH-2 enrolled 1,152 adults with obesity or overweight and type 2 diabetes. At 80 weeks, the 12 mg group...
Read MoreJoin the list for early access to new batches and research resources. No spam, unsubscribe anytime.